ScholarIQanswers from OpenAlex & ORCID
William H. Sharfman
ResearcherPublications, citations & collaboration network
William H. Sharfman is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does William H. Sharfman have?
ScholarIQindexed works
William H. Sharfman has 135 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does William H. Sharfman have?
ScholarIQcitation count
William H. Sharfman has 30,423 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of William H. Sharfman?
ScholarIQh-index
William H. Sharfman has an h-index of 46 in OpenAlex.
What is the i10-index of William H. Sharfman?
ScholarIQi10-index
William H. Sharfman has an i10-index of 84 in OpenAlex.
What is the ORCID of William H. Sharfman?
ScholarIQorcid
The ORCID for William H. Sharfman is on the source record.
What is the OpenAlex record for William H. Sharfman?
ScholarIQopenalex
The OpenAlex for William H. Sharfman is on the source record.
What are the most-cited papers on William H. Sharfman?
ScholarIQmost cited works
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer, Scott Gettinger, David C. Smith, David F. McDermott, John D. Powderly, Richard D. Carvajal, Jeffrey A. Sosman, Michael B. Atkins, Philip D. Leming, David R. Spigel, Scott Antonia, Leora Horn, Charles G. Drake, Drew M. Pardoll, Lieping Chen, William H. Sharfman, Robert A. Anders, Janis M. Taube, Tracee L. McMiller, Haiying Xu, Alan J. Korman, Maria Jure–Kunkel, Shruti Agrawal, D. G. McDonald, Georgia Kollia, Ashok Gupta, Jon M. Wigginton, Mario Sznol
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Julie R. Brahmer, Charles G. Drake, Ira Wollner, John D. Powderly, Joel Picus, William H. Sharfman, Elizabeth Stankevich, Alice Pons, Theresa M. Salay, Tracee L. McMiller, Marta M. Gilson, Changyu Wang, Mark Selby, Janis M. Taube, Robert A. Anders, Lieping Chen, Alan J. Korman, Drew M. Pardoll, Israel Lowy, Suzanne L. Topalian
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
Valsamo Anagnostou, Kellie N. Smith, Patrick M. Forde, Noushin Niknafs, Rohit Bhattacharya, James R. White, Theresa Zhang, Vilmos Adleff, Jillian Phallen, Neha Wali, Carolyn Hruban, Violeta Beleva Guthrie, Kristen Rodgers, Jarushka Naidoo, Hyunseok Kang, William H. Sharfman, Christos Georgiades, Franco Verde, Peter B. Illei, Qing Kay Li, Edward Gabrielson, Malcolm V. Brock, Cynthia A. Zahnow, Stephen B. Baylin, Robert B. Scharpf, Julie R. Brahmer, Rachel Karchin, Drew M. Pardoll, Victor E. Velculescu